Companies › ANIX

ANIXA BIOSCIENCES INC (ANIX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000715446 · EDGAR filings · Updated 2026-07-28

ANIXA BIOSCIENCES INC (ANIX) has reported institutional ownership of 15.0%, with 60 institutional managers holding positions valued at $13.1M per the latest 13F reporting period.

Filings this week (3)

• 2026-07-28 — Insider transaction reported (Form 4)
• 2026-07-27 — Insider transaction reported (Form 4)
• 2026-07-27 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-21 — Insider transaction reported (Form 4)
• 2026-07-20 — Insider transaction reported (Form 4)
• 2026-07-16 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ANIXA BIOSCIENCES INC has 60 institutional holders and institutional ownership of 15.0%.

Insider activity

Insiders reported 10 transactions (7 buys, 0 sells) across 3 reporting insiders, with a net reported value of $169.6K.

Related companies

PALATIN TECHNOLOGIES INC (PTN) · Alpha Pro Tech Ltd (APT) · NRX PHARMACEUTICALS INC (NRXP) · KAZIA THERAPEUTICS LTD (KZIA) · ATARA BIOTHERAPEUTICS COM NEW (ATRA) · FITLIFE BRANDS INC (FTLF)